Skip to main content
    H

    Heron Therapeuti (HRTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.28
    -0.03 (-8.44%)

    Market Cap: $59.08M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    45%(18/40)
    Avg Surprise
    -2.77%

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.03
    Range-$0.04 - -$0.02
    4 analysts
    Revenue Consensus
    $34.68M
    Range$30.87M - $38.33M
    4 analysts
    Report date not yet scheduledPeriod ending Mar 31, 2027
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    0 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-14.50%Operating Margin-5.69%
    ROE-217.80%ROIC-8.39%
    Financial Health
    Debt/Equity25.63xInterest CoverageN/A
    Current Ratio2.33xQuick Ratio1.31x
    Trading Statistics
    Beta1.65Avg Volume9.25M
    52-Week High$1.5752-Week Low$0.26

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 12.9% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 42.4, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$0.32
    SMA 20$0.31
    SMA 50$0.33
    SMA 200$0.64
    EMA 10$0.32
    EMA 20$0.32
    EMA 50$0.34
    EMA 200$0.62

    MACD

    Line: -0.00Signal: -0.01Hist: 0.00

    ADX

    ADX: 20.5+DI: 21.1-DI: 22.7

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down72.0
    PSAR$0.42

    Bollinger Bands

    Upper Band$0.37
    Lower Band$0.25
    %B Position3903%(Upper)
    Band Width0.27

    RSI (14-Day)

    Neutral
    42.4

    Momentum Oscillators

    Stoch %K26.5
    Stoch %D41.9
    Williams %R-88.2
    ROC (10d)-3.7%
    Momentum-0.01
    CCI (20d)-53.4
    MFI (14d)81.3

    Volatility Measures

    ATR (14d)$0.04(14.5%)
    StdDev (20d)0.03
    Hist Vol129.5%(High)

    Volume Flow

    VWAP$0.29
    OBV36.5M
    AD Line-167.3M
    CMF (20d)-0.376

    Volume Metrics

    Avg Vol (20d)9.6M
    Vol Ratio0.6x
    VWMA (20d)$0.36

    Pivot Points

    R3$0.39
    R2$0.37
    R1$0.34
    Pivot Point$0.33
    S1$0.29
    S2$0.28
    S3$0.25

    Advanced Oscillators

    TSI-3.52
    Ultimate Osc42.6
    KST-54.23

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about HRTX

    News

    HRTX Valuation

    Heron Therapeuti (HRTX) trades at 47.0x forward earnings.

    Forward P/E
    47.0x
    P/B
    14.0x
    HRTX valuation multiples

    HRTX Profitability: Margins, ROIC and FCF

    Heron Therapeuti (HRTX) has a gross margin of 71.5%, an operating margin of -5.7% and a net margin of -14.5%. It posts -8.4% ROIC and a -9.7% FCF margin.

    Gross margin
    71.5%
    Operating margin
    -5.7%
    Net margin
    -14.5%
    ROIC
    -8.4%
    ROE
    -217.8%
    FCF margin
    -9.7%
    HRTX financial statements

    Heron Therapeuti Competitors

    The companies most similar to Heron Therapeuti (HRTX) include Coherus BioSciences, Gain Therapeutics and Werewolf Therapeutics.

    Sector: Healthcare

    Companies most similar to Heron Therapeuti

    HRTX Bull Case vs Bear Case

    Bear case

    • HRTX has a -14.5% net profit margin.
    • HRTX beat EPS estimates in 37.5% of its last 8 reported quarters.
    • HRTX's quarterly revenue changed -7.8% year over year.

    HRTX Earnings: Beat Rate and Next Report

    Heron Therapeuti (HRTX) beat the EPS estimate in 3 of the last 8 quarters (37.5%).

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -17.1%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.03
    HRTX earnings history

    HRTX Earnings Call

    The latest HRTX earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    See insider activity

    Updated Nov 9, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About HRTX

    Does HRTX pay dividends?

    Heron Therapeuti (HRTX) does not currently pay a regular dividend.

    What is HRTX's market cap?

    Heron Therapeuti (HRTX) has a market capitalization of $59.08M with a current stock price of $0.28.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.